Document Detail


Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
MedLine Citation:
PMID:  11041458     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this prospective, follow-up study was to examine the influence of overt hypothyroidism (OHP) and subclinical (SHP), before and during thyroxine (T4) treatment, on lipoprotein(a) [Lp(a)], other lipoproteins, and apolipoproteins. Twenty-four patients (17 females, 7 males) with OHP, aged 54 +/- 11.1 years (group A) and 23 patients (females) with SHP aged 50.1 +/- 13.2 years (group B) were evaluated and compared to 34 and 38 controls, respectively. All patients received T4 therapy in a stepwise fashion until euthyroidism was reached. Thyrotropin (TSH), free thyroxine (FT4), and total triiodothyronine (TT3) levels were measured before T4 therapy and repeatedly every 4 weeks after the initiation of treatment until the euthyroid state was reached. Levels of Lp(a), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDLc), high-density lipoprotein cholesterol (HDLc), apolipoprotein A1 (apoA1) and apolipoprotein B (apoB) were measured before and 4 months after the achievement of euthyroidism. Additionally, body mass index (BMI) was also evaluated. We found that in OHP patients, levels of TC, LDLc, and apoB were elevated before treatment and decreased significantly after the return to the euthyroid state. BMI and levels of triglycerides also decreased significantly; Lp(a) was higher in OHP patients in comparison with controls and decreased significantly by 14.56% (25.29% in men and 10.34% in women) during T4 treatment. In SHP patients, levels of all common lipoproteins, apolipoproteins, and Lp(a) did not differ significantly from controls before treatment and did not change after the euthyroid stage was reached. It is concluded that in overt hypothyroidism, Lp(a) levels and most of the lipoproteins were elevated before treatment and decreased significantly. In subclinical hypothyroidism, lipoproteins and Lp(a) levels were normal at baseline and did not change during treatment.
Authors:
T Tzotzas; G E Krassas; T Konstantinidis; M Bougoulia
Related Documents :
2670308 - Protection against clinical endotoxemia in horses by using plasma containing antibody t...
2976858 - Reduction of lp(a) by different methods of plasma exchange.
3542358 - Enzyme immunoassay for the quantitation of immunoglobulin m class antibodies to salmone...
8637078 - Reduction of circulating prostaglandin e2 level by antiserum against core lipopolysacch...
6466158 - Interdosage fluctuations in plasma carbamazepine concentration determine intermittent s...
7156708 - Iodothyronine and thyrotropin concentrations after iodoamide administration for angiogr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thyroid : official journal of the American Thyroid Association     Volume:  10     ISSN:  1050-7256     ISO Abbreviation:  Thyroid     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2001-01-17     Completed Date:  2001-02-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9104317     Medline TA:  Thyroid     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  803-8     Citation Subset:  IM    
Affiliation:
Department of Endocrinology and Metabolism, Panagia Hospital, Thessaloniki, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Apolipoprotein A-I / blood
Apolipoproteins B / blood
Body Mass Index
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Female
Humans
Hypothyroidism / blood*,  drug therapy*
Lipoprotein(a) / blood*
Male
Middle Aged
Regression Analysis
Thyrotropin / blood
Thyroxine / blood,  therapeutic use
Triglycerides / blood
Triiodothyronine / blood
Chemical
Reg. No./Substance:
0/Apolipoprotein A-I; 0/Apolipoproteins B; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Lipoprotein(a); 0/Triglycerides; 57-88-5/Cholesterol; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with mya...
Next Document:  Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor...